Advertisement

Topics

Companies Related to "Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia" [Most Relevant Company Matches] RSS

00:25 EST 21st February 2019 | BioPortfolio

Here are the most relevant search results for "Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia" found in our extensive corporate database of over 50,000 company records.

Showing "Safety Effectiveness Azidothymidine Positive Patients With Hemophilia" Companies 1–25 of 5,500+

Relevant

Advanced Sterilization Products

Advanced Sterilization Products (ASP) division of Ethicon, Inc., is a leading developer of innovative instrument sterilization, high-level disinfection, and cleaning technologies. The company is dedicated to protecting patients, healthcare workers, and the environment with products that focus as much on safety as they do on efficacy and cost-effectiveness. Utilizing advanced instrument processing ...


The National Hemophilia Foundation

The National Hemophilia Foundation is dedicated to finding better treatments and cures for bleeding and clotting disorders and to preventing the complications of these disorders through education, advocacy and research.

World Federation of Hemophilia (WFH)

The World Federation of Hemophilia (WFH) is an international not-for-profit organization dedicated to improving the lives of people with hemophilia and related bleeding disorders. Established in 1963, it is a global network of patient organizations in 113 countries and has official recognition from the World Health Organization. Visit WFH online at www.wfh.org.


Bioverativ Inc. & Sobi

Bioverativ (NASDAQ: BIVV) is a global biopharmaceutical company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development and commercialization of innovative therapies. Launched in 2017 following separation from Biogen Inc., Bioverativ builds upon a strong heritage of scientific i...

Bioverativ Inc. and Sobi

Bioverativ (NASDAQ: BIVV) is a global biopharmaceutical company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development and commercialization of innovative therapies. Launched in 2017 following separation from Biogen Inc., Bioverativ builds upon a strong heritage of scientific i...

Bioverativ Inc.

Bioverativ (NASDAQ: BIVV) is a global biotechnology company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development and commercialization of innovative therapies. Launched in 2017 following separation from Biogen Inc., Bioverativ builds upon a strong heritage of scientific innov...

Inspiration Biopharmaceuticals, Inc.

Inspiration Biopharmaceuticals is dedicated exclusively to developing treatments for hemophilia, with a primary mission to broaden access to care, including prophylactic therapy, and improve the treatment of individuals with inhibitor complications. Inspiration has a broad development portfolio, which includes advanced, clinical-stage product candidates for the treatment of hemophilia A and hemop...

Bioverativ Inc.,

Bioverativ, a Sanofi company, is dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development, and commercialization of innovative therapies. Bioverativ is committed to actively working with the blood disorders community, and its hemophilia therapies, when launched, represented the f...

Dimension Therapeutics, Inc.

Dimension Therapeutics, Inc. is a gene therapy company focused on developing novel treatments for patients with hemophilia and rare diseases. Dimension has built a product development pipeline based on an industry-leading adeno-associated virus (AAV) platform, and the Company is advancing multiple gene therapy programs toward clinical development. These pr...

REGISTRAT®, Inc

REGISTRAT Mission Statement is To partner with our sponsors, the scientific community, healthcare providers and patients to conduct quality research, advance scientific knowledge, gain clinical insights, and optimize the effectiveness and safety of medical products.

World Federation of Hemophilia

The World Federation of Hemophilia (WFH) is an international not-for-profit organization dedicated to improving the lives of people with hemophilia and other inherited bleeding disorders. Established in 1963, it is a global network of patient organizations in 118 countries and has official recognition from the World Health Organization. Visit WFH online at...

Syntonix Pharmaceuticals, Inc.

Syntonix is developing next generation biopharmaceuticals that enable better treatment options for patients with devastating chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company applies its core technologies to develop long-acting biopharmaceuticals that may be inhaled or injected less frequently, and to discover novel drugs to treat antibody-media...

The National Patient Safety Foundation

The National Patient Safety Foundation (NPSF) has been pursuing one mission since its founding in 1997 - to improve the safety of care provided to patients. As a central voice for patient safety, NPSF is committed to a collaborative, inclusive, multi-stakeholder approach in all that it does. NPSF is an independent, not-for-profit 501(c)(3) organization. To learn more about the work of the National...

Tennessee Center for Patient Safety

The mission of the Tennessee Center for Patient Safety is to advance Tennessee hospitals’ adoption of proven strategies that enhance the reliability, safety and quality of care received by patients. Established in 2007, the Tennessee Center for Patient Safety primarily is funded by the BlueCross BlueShield of Tennessee Health Foundation and operated b...

Accredo Health

Accredo Health, Incorporated ("Accredo") is a Memphis-based parent organization for a family of companies providing specialized contract pharmacy and related services beneficial to patients with certain costly, chronic diseases. Through its affiliated companies, Hemophilia Health Services, Inc., Nova Factor, Inc., and Sunrise Health Management, Inc., Accredo has designed its specialty services to ...

Baxter Healthcare Corporation

Baxter International Inc. (NYSE:BAX) is a global healthcare company that, through its subsidiaries assists healthcare professionals and their patients with treatment of complex medical conditions including hemophilia, immune disorders, kidney disease, cancer, trauma and other conditions. With 2007 sales of $11.3 billion, and approximately 46,500 employees, Baxter applies its expertise in medical d...

National Comprehensive Cancer Network

The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that prese...

National Comprehensive Cancer Network (NCCN)

The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that prese...

bioTheranostics, Inc.

bioTheranostics discovers, develops, and commercializes a growing array of molecular diagnostic tests for cancer patients. Leveraging its unique expertise in expression profiling and algorithm development, bioTheranostics is well positioned to be a partner and solution provider in metastatic cancer. The company operates a CLIA-certified, CAP-accredited dia...

Biogen Inc.

Through cutting-edge science and medicine, Biogen discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies and patients worldwide benefit from its ...

The National Comprehensive Cancer Network (NCCN)

The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that prese...

SharedClarity

SharedClarity is a unique joint effort between health care systems and UnitedHealthcare to use data from tens of millions of patients to study the long-term effectiveness of high-technology medical devices that have a high impact on patients. SharedClarity will use the results of the studies to select the best devices for patients and negotiate affordable ...

National Comprehensive Cancer Network and National Business Group on Health

The National Comprehensive Cancer Network, a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable inf...

Biomed Pharmaceuticals

The Company is a leading pharmacy provider of intravenous and injectable medications for patients with chronic disorders. Biomed treats a variety of immune deficient and autoimmune disorders through Intravenous Immunoglobulin (“IVIG”) therapy, as well as hemophilia and Rheumatoid Arthritis. In addition to filling a patient’s prescriptions, Biomedâ...

Cliffside Malibu

Cliffside Malibu is a full-service residential drug treatment program and alcohol addiction treatment center in the Los Angeles area. At Cliffside, a team of highly trained experts administer individually tailored rehabilitation programs for every type of addiction to patients who place a premium on privacy, safety, and, most importantly, effectiveness. The drug rehabilitation facility gets its ...


More From BioPortfolio on "Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks